gemtuzumab ozogamicin /gemto̅o̅′zo̅o̅mab″ o″zo-gah-mi′sin/ , a recombinant DNA-derived monoclonal antibody conjugated with a cytotoxic antitumor antibiotic used as an antineoplastic in the treatment of relapsed acute myelogenous leukemia, administered intravenously.
